As expected, lactate treatment increased TPX2 lactylation in HCC cells (Fig 1D), and the lactate dehydrogenase A (LDHA) inhibitors GSK2837808A and sodium oxamate had opposite effects (Figs 1E and S1E). The gene discussed is LDHA; the disease is hepatocellular carcinoma.